Antibiotic prophylaxis in patients receiving hematopoietic stem cell transplant

Bone Marrow Transplantation

Volumn 29, Issue 5, 2002, Pages 367-371

  Sepkowitz, K A ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

Bacterial infections; Drug resistance; Prophylaxis; Sepsis

Indexed keywords

AMINOGLYCOSIDE; AMOXICILLIN PLUS CLAVULANIC ACID; ANTIBIOTIC AGENT; BETA LACTAM; CEPHALOSPORIN DERIVATIVE; CIPROFLOXACIN; COTRIMOXAZOLE; CYCLOPHOSPHAMIDE; CYTARABINE; IMIPENEM; LEVOFLOXACIN; LINEZOLID; METRONIDAZOLE; NEOMYCIN; PENICILLIN G; POLYMYXIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RAMOPLANIN; STREPTOMYCIN;

ANTIBIOTIC PROPHYLAXIS; ANTIBIOTIC RESISTANCE; BACTEREMIA; BACTERIAL INFECTION; CONTROLLED STUDY; DRUG EFFICACY; DRUG USE; ENTEROCOCCUS; GRAFT SURVIVAL; GRAFT VERSUS HOST REACTION; GRAM NEGATIVE INFECTION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; INFECTION CONTROL; PRACTICE GUIDELINE; PRIORITY JOURNAL; SHORT SURVEY; STOMATITIS; TUBERCULOUS MENINGITIS; OPPORTUNISTIC INFECTION; REVIEW;

ANTIBIOTIC PROPHYLAXIS; BACTERIAL INFECTIONS; DRUG RESISTANCE, BACTERIAL; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; OPPORTUNISTIC INFECTIONS;

EID: 85047682162     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1703366     Document Type: Short Survey

References (24)

1. Guidelines for preventing opportunistic infections among hematopoietic stem cell transplant recipients: Recommendations of the CDC, the Blood and Marrow transplantation
2. Prophylaxis with fluoroquinolones for bacterial infections in neutropenic patients: A meta-analysis
3. Efficacy of quinolone prophylaxis in neutropenic cancer patients: A meta-analysis
4. A randomized controlled trial of sulfamethoxazole/trimethoprim plus norfloxacin versus sulfamethoxazole/trimethoprim alone for the prophylaxis of bacteria infection during chemotherapy for lung cancer
5. Fluoroquinolone prophylaxis for the prevention of bacteial infections in patients with cancer
6. Infections in the immunocompromised host: General principles
7. Prevalence of ciprofloxacin-resistant Escherichia coli in hematologic-oncologic patients
8. Oral ciprofloxacin as antibacterial prophylaxis after allogeneic bone marrow transplantation: A reappraisal
9. Influence of intestinal bacterial decontamination using metronidazole and ciprofloxacin or ciprofloxacin alone on the development of acute patients with hematologic malignancies: Final results and long-term follow-up of an open-label prospective randomized trial
10. Risk factors in bone marrow transplant recipients with leukaemia. Increased relapse risk in patients treated with ciprofloxacin for gut decontamination
11. Escherichia coli resistant to fluoroquinolones in patients with cancer and neutropenia
12. Clinical prevalence, antimicrobial susceptibility, and geographic resistance patterns of enterococci: Results from the SENTRY Antimicrobial Surveillance Program, 1997-1999
13. Linezolid resistance in a clinical isolate of Staphylococcus aureus
14. Infections due to vancomycin-resistant Enterococcus faecium resistant to linezolid
15. Prevention of gram-positive infections after bone marrow transplantation by systemic vancomycin: A prospective, randomized trial
16. Septicemia and shock syndrome due to viridans streptococci: A case-control study of predisposing factors
17. Bacteremia due to viridans streptococcus in neutropenic patients with cancer: Clinical spectrum and risk factors
18. Serious complications of bacteremia caused by Viridans streptococci in neutropenic patients with cancer
19. Bacteremia due to viridans streptococci in neutropenic patients: A review
20. Antimicrobial resistance in viridans group streptococci among patients with and without the diagnosis of cancer in the USA, Canada and Latin America
21. Two consecutive outbreaks of Stenotrophomonas maltophilia (Xanthomonas maltophilia) in an intensive-care unit defined by restriction fragment-length polymorphism typing
22. The increasing role of Acinetobacter species as nosocomial pathogens
23. Effect of antibiotic therapy on the density of vancomycin-resistant enterococci in the stool of colonized patients
24. The incidence of antimicrobial allergies in hospitalized patients: Implications regarding prescribing patterns and emerging bacterial resistance